Metronidazole 500 mg
Sponsors
Merck Sharp & Dohme LLC, Inje University, Konstantopoulio-Patission General Hospital of Nea Ionia, dr. IJM Han-Geurts, Tulane University
Conditions
Bacterial VaginitisBacterial VaginosisBacterial Vaginosis (BV)Complicated Intra-abdominal InfectionDrain AbscessHelicobacter Pylori InfectionIntra-abdominal InfectionPerianal Abscess
Phase 2
Phase 3
Phase 4
Helicobacter Pylori Eradication Study
CompletedNCT03130452
Start: 2016-12-17End: 2019-05-31Updated: 2025-05-01
Genotypic Resistance-guided Versus Empirical Therapy for H. Pylori Eradication.
NCT04090021
Start: 2019-09-01End: 2020-02-28Target: 304Updated: 2019-09-19
Refining Treatment Options for Trichomonas Vaginalis Infection: A Comparative Analysis of Metronidazole and Secnidazole
RecruitingNCT06261840
Start: 2025-05-06End: 2029-07-31Target: 1200Updated: 2025-06-06
Improvement of PPROM Management With Prophylactic Antimicrobial Therapy (iPROMPT)
RecruitingNCT06396078
Start: 2024-07-18End: 2026-12-01Target: 56Updated: 2026-01-27
Optimization of Bacterial Vaginosis Treatment in Women of Reproductive Age
RecruitingNCT06458543
Start: 2024-06-01End: 2026-06-01Target: 100Updated: 2025-04-09